Page last updated: 2024-12-07

3-hydroxyphencyclidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-hydroxyphencyclidine: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID133277
CHEMBL ID123708
MeSH IDM0102912

Synonyms (21)

Synonym
1-(1-(3-hydroxyphenyl)-cyclohexyl)piperidine
79787-43-2
phenol, 3-(1-(1-piperidinyl)cyclohexyl)-
unii-v886qlhna6
pcp-3-oh
v886qlhna6 ,
3-hydroxyphencyclidine
CHEMBL123708
3-(1-piperidin-1-ylcyclohexyl)phenol
DTXSID20229918
3-hydroxy pcp
3-hydroxy pcp [nflis-drug]
n-(1-(3-hydroxyphenyl)cyclohexyl)piperidine
1-(1-(3-hydroxyphenyl)cyclohexyl)piperidine
3-(1-(1-piperidinyl)cyclohexyl)phenol
3-ho-pcp
3-oh-pcp
3-(1-(piperidin-1-yl)cyclohexyl)phenol
1-[1(3-hydroxyphenyl)cyclo-hexyl]pip eridine
Q20707014
PD078912
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (9)

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Delta-type opioid receptorMus musculus (house mouse)K0.50.06000.06000.06000.0600AID150251
Kappa-type opioid receptorMus musculus (house mouse)K0.50.06000.06000.06000.0600AID150251
Mu-type opioid receptorMus musculus (house mouse)K0.50.06000.06000.06000.0600AID150251
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)K0.50.03000.03002.69508.3000AID157449
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
plasma membraneKappa-type opioid receptorMus musculus (house mouse)
plasma membraneMu-type opioid receptorMus musculus (house mouse)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)
plasma membraneMuscarinic acetylcholine receptor M3Mus musculus (house mouse)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID150251Inhibition of the specific binding of [3H]morphine to Opioid receptors1982Journal of medicinal chemistry, Apr, Volume: 25, Issue:4
Chemical synthesis and molecular pharmacology of hydroxylated 1-(1-phenylcyclohexyl-piperidine derivatives.
AID141405Hill coefficient for binding of [3H]QNB to Muscarinic acetylcholine receptor1982Journal of medicinal chemistry, Apr, Volume: 25, Issue:4
Chemical synthesis and molecular pharmacology of hydroxylated 1-(1-phenylcyclohexyl-piperidine derivatives.
AID131541Effective dose for inhibition of phencyclidine binding measured in mouse rotarod assay1982Journal of medicinal chemistry, Apr, Volume: 25, Issue:4
Chemical synthesis and molecular pharmacology of hydroxylated 1-(1-phenylcyclohexyl-piperidine derivatives.
AID157449Inhibition of the specific binding of [3H]phencyclidine to phencyclidine receptor1982Journal of medicinal chemistry, Apr, Volume: 25, Issue:4
Chemical synthesis and molecular pharmacology of hydroxylated 1-(1-phenylcyclohexyl-piperidine derivatives.
AID150252Hill coefficient for binding of [3H]morphine to Opioid receptors1982Journal of medicinal chemistry, Apr, Volume: 25, Issue:4
Chemical synthesis and molecular pharmacology of hydroxylated 1-(1-phenylcyclohexyl-piperidine derivatives.
AID141404Inhibition of the specific binding of [3H]QNB to Muscarinic acetylcholine receptor1982Journal of medicinal chemistry, Apr, Volume: 25, Issue:4
Chemical synthesis and molecular pharmacology of hydroxylated 1-(1-phenylcyclohexyl-piperidine derivatives.
AID157450Hill coefficient for binding of [3H]phencyclidine to phencyclidine receptor1982Journal of medicinal chemistry, Apr, Volume: 25, Issue:4
Chemical synthesis and molecular pharmacology of hydroxylated 1-(1-phenylcyclohexyl-piperidine derivatives.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (63.64)18.7374
1990's2 (18.18)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (18.18)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.99

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.99 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.56 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.99)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies2 (16.67%)4.05%
Observational0 (0.00%)0.25%
Other10 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]